Le marché des médicaments imprimés en 3D était évalué à 28,52 millions de dollars américains en 2019 et devrait croître à un TCAC de 9,1 % de 2020 à 2027 pour atteindre 57,03 millions de dollars américains d'ici 2027.
Les médicaments imprimés en 3D sont des médicaments , qui sont conçus par la technique d'impression 3D pour être personnalisés pour les individus de manière plus sûre et efficace. Ces médicaments ont des structures poreuses unitaires qui se dispersent facilement dans la bouche, de sorte que ces médicaments à forte dose n'ont pas besoin d'être avalés intacts. L'idée principale derrière les médicaments imprimés en 3D est de concevoir et de développer des médicaments adaptés aux besoins d'un individu. Le marché mondial des médicaments imprimés en 3D est stimulé par des facteurs tels que l'adoption croissante de médicaments personnalisés. De plus, la croissance des activités de recherche et développement, associée à la prévalence croissante de la dysphagie, devrait également stimuler la croissance du marché 3D au cours de la période de prévision. Cependant, l'utilisation de l'impression 3D pour développer des drogues illégales freine la croissance du marché. Le développement des infrastructures de santé et la sensibilisation croissante à l'impression 3D dans les produits pharmaceutiques génèrent des opportunités lucratives pour la croissance du marché.
Marchés régionaux lucratifs des médicaments imprimés en 3D
Aperçu du marché
Accroissement de l'adoption des médicaments personnalisés
La médecine personnalisée est un domaine de traitement en plein essor qui repose sur l'administration et le dosage de médicaments spécifiques. Selon une étude publiée par PMC, les médicaments personnalisés ne représentaient que 5 % des nouvelles entités moléculaires approuvées par la FDA en 2005 ; alors qu'en 2016, ils représentaient plus de 25 %. De plus, 42 % de tous les composés et 73 % des composés oncologiques en cours de développement ont le potentiel d'être des médicaments personnalisés. De plus, les sociétés biopharmaceutiques ont presque doublé leurs investissements en R&D dans les médicaments personnalisés au cours des cinq dernières années et prévoient d'augmenter leurs investissements de 33 % au cours des cinq prochaines années. Les chercheurs biopharmaceutiques prédisent également une augmentation de 69 % du nombre de médicaments personnalisés en développement au cours des cinq prochaines années.
L'impression 3D offre la possibilité de créer un système de médecine personnalisée grâce à un contrôle automatisé de la dose de médicament et convient aux concentrations de médicaments faibles et élevées. Ces avantages permettent aux sociétés pharmaceutiques non seulement d'augmenter l'efficacité et l'observance, mais aussi de contribuer à la longévité de leur marque en élargissant et en conquérant des parts de marché avec d'autres formes posologiques. Grâce à cette méthode de fabrication révolutionnaire et à ses capacités de fusion rapide, il est possible de surmonter plusieurs obstacles, contribuant ainsi à de meilleurs résultats pour les patients sur le marché des doses solides. Par exemple, FabRx Ltd. a réalisé la première étude clinique humaine au monde en utilisant sa technologie exclusive Printlets, qui repose sur des formes posologiques personnalisées imprimées en 3D pour traiter les enfants atteints d'une maladie métabolique rare. De plus, la même société a lancé la première imprimante 3D pharmaceutique, M3DIMAKER, pour la fabrication de médicaments personnalisés en avril 2020. Par conséquent, il existe un besoin de nouveaux systèmes de fabrication pour préparer des médicaments personnalisés, et cette application potentielle de l'impression 3D pour les maladies rares est innombrable. Cela pourrait aider à rendre le médicament plus sûr et plus attrayant pour les enfants, propulsant ainsi la croissance du marché des médicaments imprimés en 3D.
Informations basées sur la forme posologique
Sur la base de la forme posologique, le médicament imprimé en 3D Le marché des médicaments est segmenté en comprimés, gélules, implants multi-médicaments, nanoparticules, solutions et autres formes posologiques. En 2019, le segment des tablettes détenait la plus grande part du marché, et il devrait en outre enregistrer le TCAC le plus élevé du marché au cours de la période de prévision. À l'heure actuelle, les médicaments imprimés en 3D ne sont disponibles que sous forme de comprimés sur le marché. Cependant, les autres formes galéniques sont susceptibles d'être commercialisées dans les années à venir.
Marché des médicaments imprimés en 3D, par forme posologique - 2019 et 2027
Insights basés sur la technologie
Basé sur la technologie, le marché des médicaments imprimés en 3D est segmenté en impression à jet d'encre , écriture directe, dose zip, impression jet d'encre thermique, modélisation par dépôt de fusion, impression sur lit de poudre, stéréolithographie (SLA) et extrusion semi-solide (SSE). Le segment de la technologie des doses zippées détenait la plus grande part de marché ; de plus, il devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Perspectives stratégiques
Les lancements de produits et l'approbation de la FDA sont une stratégie couramment adoptée par les entreprises pour étendre leur présence dans le monde entier et répondre à la demande croissante, car la stratégie leur permet d'élargir leurs portefeuilles de produits.
Les acteurs du marché des médicaments imprimés en 3D adoptent également la stratégie de collaborations, ce qui leur permet d'élargir leur clientèle mondiale, tout en les aidant à conserver leurs noms de marque.
Marché des médicaments imprimés en 3D - Par formes posologiques
- Comprimés
- Capsules
- Implants multi-médicaments
- Nanoparticules
- Solutions
- Autres
Marché des médicaments imprimés en 3D - Par technologie
- Impression à jet d'encre
- Écriture directe
- Zip Dose< /li>
- Impression à jet d'encre thermique
- Modélisation par dépôt de fil fondu
- Impression sur lit de poudre
- Stéréolithographie (SLA)
- Extrusion semi-solide (SSE)
Marché des médicaments imprimés en 3D Par zone géographique
- Amérique du Nord
- États-Unis
- Canada
- Mexique
- Europe
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Asie-Pacifique
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
- Moyen-Orient et Afrique
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient et Afrique
< /ul>
- Amérique du Sud
- Brésil
- Argentine
- Reste de l'Amérique du Sud
Profils des sociétés
- APRECIA PHARMACEUTICALS, LLC
- FabRx LTD
- Cycle Pharmaceuticals
- GLAXOSMITHKLINE PLC .
- ASTRAZENECA
- Tvasta
- Merck KGGA
- Terumo Corporation
- États-Unis
- Canada
- Mexique
- France
- Allemagne
- Italie
- Royaume-Uni
- Espagne
- Reste de l'Europe
- Chine
- Inde
- Corée du Sud
- Japon
- Australie
- Reste de l'Asie-Pacifique
- Afrique du Sud
- Arabie saoudite
- EAU
- Reste du Moyen-Orient et Afrique
< /ul>
- Brésil
- Argentine
- Reste de l'Amérique du Sud
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
3D Printed Drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.
Increasing awareness of benefits offered by 3D printed drugs and growing emphasis on personalized medicines
Aprecia Pharmaceuticals, LLC and FabRx LTD are the major players in the market.
The List of Companies - 3D Printed Drugs Market
- APRECIA PHARMACEUTICALS, LLC
- FabRx LTD
- Cycle Pharmaceuticals
- GLAXOSMITHKLINE PLC.
- ASTRAZENECA
- Tvasta
- Merck KGGA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2020
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2020
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2020
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)